Boai NKY Medical Holdings Ltd. (300109.SZ)
CNY 15.15
(1.88%)
CNY 15.15
(1.88%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.58 Billion CNY | 7.03% |
| 2022 | 1.48 Billion CNY | 21.75% |
| 2021 | 1.22 Billion CNY | 24.71% |
| 2020 | 978.52 Million CNY | 5.85% |
| 2019 | 924.42 Million CNY | 32.39% |
| 2018 | 698.28 Million CNY | 42.92% |
| 2017 | 488.58 Million CNY | 21.96% |
| 2016 | 400.61 Million CNY | 37.84% |
| 2015 | 290.63 Million CNY | 14.72% |
| 2014 | 253.34 Million CNY | 20.99% |
| 2013 | 209.38 Million CNY | -1.62% |
| 2012 | 212.84 Million CNY | 11.59% |
| 2011 | 190.73 Million CNY | 16.79% |
| 2010 | 163.31 Million CNY | 25.54% |
| 2009 | 130.08 Million CNY | 19.69% |
| 2008 | 108.68 Million CNY | 30.26% |
| 2007 | 83.43 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 376.19 Million CNY | 10.61% |
| 2024 Q2 | 340.11 Million CNY | -13.83% |
| 2024 Q1 | 394.68 Million CNY | 2.89% |
| 2023 Q2 | 416.01 Million CNY | 14.6% |
| 2023 Q3 | 427.51 Million CNY | 2.77% |
| 2023 Q4 | 383.61 Million CNY | -10.27% |
| 2023 FY | 1.59 Billion CNY | 7.03% |
| 2023 Q1 | 363 Million CNY | 1.01% |
| 2022 Q3 | 447.88 Million CNY | 21.86% |
| 2022 FY | 1.48 Billion CNY | 21.75% |
| 2022 Q4 | 359.37 Million CNY | -19.76% |
| 2022 Q2 | 367.55 Million CNY | 18.24% |
| 2022 Q1 | 310.86 Million CNY | -12.39% |
| 2021 FY | 1.22 Billion CNY | 24.71% |
| 2021 Q3 | 329.06 Million CNY | 30.72% |
| 2021 Q1 | 284.64 Million CNY | -2.61% |
| 2021 Q2 | 251.73 Million CNY | -11.56% |
| 2021 Q4 | 354.82 Million CNY | 7.83% |
| 2020 Q4 | 292.28 Million CNY | 21.12% |
| 2020 FY | 978.52 Million CNY | 5.85% |
| 2020 Q3 | 241.33 Million CNY | 7.51% |
| 2020 Q2 | 224.47 Million CNY | 1.83% |
| 2020 Q1 | 220.43 Million CNY | -16.33% |
| 2019 Q4 | 263.45 Million CNY | -0.52% |
| 2019 FY | 924.42 Million CNY | 32.39% |
| 2019 Q1 | 157.51 Million CNY | -27.65% |
| 2019 Q2 | 238.61 Million CNY | 51.48% |
| 2019 Q3 | 264.84 Million CNY | 10.99% |
| 2018 Q2 | 169.72 Million CNY | 21.78% |
| 2018 Q1 | 139.37 Million CNY | -0.66% |
| 2018 FY | 698.28 Million CNY | 42.92% |
| 2018 Q4 | 217.7 Million CNY | 26.95% |
| 2018 Q3 | 171.48 Million CNY | 1.04% |
| 2017 FY | 488.58 Million CNY | 21.96% |
| 2017 Q4 | 140.3 Million CNY | 19.65% |
| 2017 Q3 | 117.26 Million CNY | -6.2% |
| 2017 Q2 | 125.01 Million CNY | 17.94% |
| 2017 Q1 | 105.99 Million CNY | -0.3% |
| 2016 Q4 | 106.31 Million CNY | 15.79% |
| 2016 FY | 400.61 Million CNY | 37.84% |
| 2016 Q1 | 92.34 Million CNY | 6.83% |
| 2016 Q2 | 110.14 Million CNY | 19.27% |
| 2016 Q3 | 91.81 Million CNY | -16.64% |
| 2015 Q3 | 77.38 Million CNY | 20.38% |
| 2015 FY | 290.63 Million CNY | 14.72% |
| 2015 Q1 | 62.51 Million CNY | 6.23% |
| 2015 Q2 | 64.28 Million CNY | 2.83% |
| 2015 Q4 | 86.44 Million CNY | 11.71% |
| 2014 Q1 | 60.28 Million CNY | 23.33% |
| 2014 FY | 253.34 Million CNY | 20.99% |
| 2014 Q4 | 58.85 Million CNY | -14.71% |
| 2014 Q3 | 69 Million CNY | 5.84% |
| 2014 Q2 | 65.19 Million CNY | 8.14% |
| 2013 Q4 | 48.88 Million CNY | 0.38% |
| 2013 Q2 | 59.35 Million CNY | 13.18% |
| 2013 Q3 | 48.69 Million CNY | -17.96% |
| 2013 Q1 | 52.44 Million CNY | 12.01% |
| 2013 FY | 209.38 Million CNY | -1.62% |
| 2012 Q4 | 46.82 Million CNY | -3.44% |
| 2012 Q1 | 54.31 Million CNY | 15.45% |
| 2012 FY | 212.84 Million CNY | 11.59% |
| 2012 Q2 | 63.22 Million CNY | 16.39% |
| 2012 Q3 | 48.48 Million CNY | -23.31% |
| 2011 Q1 | 45.44 Million CNY | 6.16% |
| 2011 Q3 | 48.11 Million CNY | -4.02% |
| 2011 FY | 190.73 Million CNY | 16.79% |
| 2011 Q4 | 47.04 Million CNY | -2.22% |
| 2011 Q2 | 50.12 Million CNY | 10.31% |
| 2010 Q1 | 34.54 Million CNY | 14.0% |
| 2010 Q2 | 41.55 Million CNY | 20.31% |
| 2010 FY | 163.31 Million CNY | 25.54% |
| 2010 Q4 | 42.8 Million CNY | -3.59% |
| 2010 Q3 | 44.4 Million CNY | 6.84% |
| 2009 Q3 | 40.14 Million CNY | 0.0% |
| 2009 Q4 | 30.3 Million CNY | -24.51% |
| 2009 FY | 130.08 Million CNY | 19.69% |
| 2008 FY | 108.68 Million CNY | 30.26% |
| 2007 FY | 83.43 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 32.05 Billion CNY | 95.06% |
| Zhejiang Zhenyuan Share Co., Ltd. | 4.1 Billion CNY | 61.44% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 656.89 Million CNY | -141.046% |
| Hubei Guangji Pharmaceutical Co., Ltd. | 737.81 Million CNY | -114.608% |
| Yifan Pharmaceutical Co., Ltd. | 4.02 Billion CNY | 60.633% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 533.23 Million CNY | -196.947% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 21.15 Billion CNY | 92.514% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 895.59 Million CNY | -76.801% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 848.19 Million CNY | -86.682% |